Clinical trial
Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis
NCT06267365 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis
- Lead sponsor
- NYU Langone Health
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 27, 2023
- Completion date
- June 1, 2028
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pancreatitis